Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids

Chemistry and Physics of Lipids

Volumn 181, Issue , 2014, Pages 1-33

  Davies, Sean S ^a   Guo, Lilu ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD36; Lipid aldehydes; Lipid peroxidation; Oxidized phospholipids; Platelet activating factor acetyl hydrolase; Toll like receptors

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARYLDIALKYLPHOSPHATASE; CALCIUM CHANNEL L TYPE; CALCIUM IONOPHORE; CYTOCHROME P450; ENDOPEROXIDE; GLUTATHIONE PEROXIDASE; HYDROXYICOSATETRAENOIC ACID; HYDROXYOCTADECAENOATE; ISOPROSTANE DERIVATIVE; LONG CHAIN FATTY ACID COENZYME A LIGASE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOPEROXIDASE; OXIDATIVELY MODIFIED PHOSPHOLIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID DERIVATIVE; PHOSPHOLIPID HYDROPEROXIDE; PLASMALOGEN; POLYUNSATURATED FATTY ACID; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; PHOSPHOLIPID;

ANGIOGENESIS; ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASTHMA; ATHEROSCLEROSIS; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CHEMICAL REACTION; CHIRAL CHROMATOGRAPHY; CHOLESTEROL TRANSPORT; CORONARY ARTERY DISEASE; CYSTIC FIBROSIS; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; DOWN REGULATION; ENANTIOMER; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; ERYTHROCYTE; ESTERIFICATION; FAMILIAL COLON POLYPOSIS; FOAM CELL; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOCK REARRANGEMENT; HUMAN; IMMUNOREACTIVITY; INTESTINE POLYP; KERATINOCYTE; LEUKOCYTE; LIPID HYDROLYSIS; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; LUNG ALVEOLUS CELL; LUNG LAVAGE; MACROPHAGE; MASS FRAGMENTOGRAPHY; MITOCHONDRIAL RESPIRATION; MONOCYTE; MUSCLE FIBER CONTRACTION; NEUTROPHIL; NOMENCLATURE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; OXYGENATION; PHAGOCYTOSIS; PRIORITY JOURNAL; RADICAL REACTION; RETINA MACULA AGE RELATED DEGENERATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SODIUM CURRENT; STEREOISOMERISM; STEROL METABOLISM; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE ACTIVATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ULTRAVIOLET B RADIATION; UPREGULATION; VASCULAR SMOOTH MUSCLE; WILD TYPE; ANIMAL; CHEMISTRY; METABOLISM;

ANIMALS; HUMANS; LIPID PEROXIDATION; PHOSPHOLIPIDS; SIGNAL TRANSDUCTION;

EID: 84899521996     PISSN: 00093084     EISSN: 18732941     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2014.03.002     Document Type: Review

References (302)

1. A. Acquaviva, D. Vecchio, B. Arezzini, M. Comporti, and C. Gardi Signaling pathways involved in isoprostane-mediated fibrogenic effects in rat hepatic stellate cells Free Radic. Biol. Med. 65 2013 201 207
2. Z. Ahmed, S. Babaei, G.F. Maguire, D. Draganov, A. Kuksis, B.N. La Du, and P.W. Connelly Paraoxonase-1 reduces monocyte chemotaxis and adhesion to endothelial cells due to oxidation of palmitoyl, linoleoyl glycerophosphorylcholine Cardiovasc. Res. 57 2003 225 231
3. E. Al-Shawaf, J. Naylor, H. Taylor, K. Riches, C.J. Milligan, D. O'Regan, K.E. Porter, J. Li, and D.J. Beech Short-term stimulation of calcium-permeable transient receptor potential canonical 5-containing channels by oxidized phospholipids Arterioscler. Thromb. Vasc. Biol. 30 2010 1453 1459
4. M. Aldrovandi, and V.B. O'Donnell Oxidized PLs and vascular inflammation Curr. Atheroscler. Rep. 15 2013 323
5. D. Alkazemi, G.M. Egeland, L.J. Roberts 2nd, H.M. Chan, and S. Kubow New insights regarding tissue Se and Hg interactions on oxidative stress from plasma IsoP and IsoF measures in the Canadian Inuit population J. Lipid Res. 54 2013 1972 1979
6. V. Amarnath, K. Amarnath, K. Amarnath, S. Davies, and L.J. Roberts 2nd Pyridoxamine: an extremely potent scavenger of 1,4-dicarbonyls Chem. Res. Toxicol. 17 2004 410 415
7. M.Z. Ashraf, N.S. Kar, X. Chen, J. Choi, R.G. Salomon, M. Febbraio, and E.A. Podrez Specific oxidized phospholipids inhibit scavenger receptor bi-mediated selective uptake of cholesteryl esters J. Biol. Chem. 283 2008 10408 10414
8. J.A. Awad, J.D. Morrow, K. Takahashi, and L.J. Roberts 2nd Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma J. Biol. Chem. 268 1993 4161 4169
9. M. Aziz, A. Jacob, A. Matsuda, and P. Wang Review: milk fat globule-EGF factor 8 expression, function and plausible signal transduction in resolving inflammation Apoptosis 16 2011 1077 1086
10. S. Bacot, N. Bernoud-Hubac, N. Baddas, B. Chantegrel, C. Deshayes, A. Doutheau, M. Lagarde, and M. Guichardant Covalent binding of hydroxy-alkenals 4-HDDE, 4-HHE, and 4-HNE to ethanolamine phospholipid subclasses J. Lipid Res. 44 2003 917 926
11. S. Bacot, N. Bernoud-Hubac, B. Chantegrel, C. Deshayes, A. Doutheau, G. Ponsin, M. Lagarde, and M. Guichardant Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals J. Lipid Res. 48 2007 816 825
12. S. Basu F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications Antioxid. Redox Signal. 10 2008 1405 1434
13. A. Bedirli, S. Gokahmetoglu, O. Sakrak, I. Soyuer, O. Ince, and E. Sozuer Beneficial effects of recombinant platelet-activating factor acetylhydrolase and BN 52021 on bacterial translocation in cerulein-induced pancreatitis Eur. Surg. Res. 36 2004 136 141
14. J.A. Berliner, M.C. Territo, A. Sevanian, S. Ramin, J.A. Kim, B. Bamshad, M. Esterson, and A.M. Fogelman Minimally modified low density lipoprotein stimulates monocyte endothelial interactions J. Clin. Invest. 85 1990 1260 1266
15. M. Bernareggi, G. Rossoni, and F. Berti Bronchopulmonary effects of 8-epi-PGF2A in anaesthetised guinea pigs Pharmacol. Res. Off. J. It. Pharmacol. Soc. 37 1998 75 80
16. N. Bernoud-Hubac, D.A. Alam, J. Lefils, S.S. Davies, V. Amarnath, M. Guichardant, L.J. Roberts Ii, and M. Lagarde Low concentrations of reactive [gamma]-ketoaldehydes prime thromboxane-dependent human platelet aggregation via p38-MAPK activation Biochim. Biophys. Acta (BBA) - Mol. Cell Biol. Lipids 1791 2009 307 313
17. N. Bernoud-Hubac, L.B. Fay, V. Armarnath, M. Guichardant, S. Bacot, S.S. Davies, L.J. Roberts 2nd, and M. Lagarde Covalent binding of isoketals to ethanolamine phospholipids Free Radic. Biol. Med. 37 2004 1604 1611
18. K. Bernstrom, K. Kayganich, R.C. Murphy, and F.A. Fitzpatrick Incorporation and distribution of epoxyeicosatrienoic acids into cellular phospholipids J. Biol. Chem. 267 1992 3686 3690
19. D.K. Bhuyan, R.W. Master, and K.C. Bhuyan Crosslinking of aminophospholipids in cellular membranes of lens by oxidative stress in vitro Biochim. Biophys. Acta 1285 1996 21 28
20. F.T.T. Billings, S.K. Ball, L.J. Roberts 2nd, and M. Pretorius Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response Free Radic. Biol. Med. 50 2011 1480 1487
21. A.A. Birukova, V. Starosta, X. Tian, K. Higginbotham, L. Koroniak, J.A. Berliner, and K.G. Birukov Fragmented oxidation products define barrier disruptive endothelial cell response to OxPAPC Transl. Res. J. Lab. Clin. Med. 161 2013 495 504
22. V.N. Bochkov, A. Kadl, J. Huber, F. Gruber, B.R. Binder, and N. Leitinger Protective role of phospholipid oxidation products in endotoxin-induced tissue damage Nature 419 2002 77 81
23. V.N. Bochkov, O.V. Oskolkova, K.G. Birukov, A.L. Levonen, C.J. Binder, and J. Stockl Generation and biological activities of oxidized phospholipids Antioxid. Redox Signal. 12 2010 1009 1059
24. D. Borchman, M.C. Yappert, R.Q. Rubini, and C.A. Paterson Distribution of phospholipid-malondialdehyde-adduct in the human lens Curr. Eye Res. 8 1989 939 946
25. G.G. Borisenko, S.L. Iverson, S. Ahlberg, V.E. Kagan, and B. Fadeel Milk fat globule epidermal growth factor 8 (MFG-E8) binds to oxidized phosphatidylserine: implications for macrophage clearance of apoptotic cells Cell Death Differ. 11 2004 943 945
26. A. Boullier, P. Friedman, R. Harkewicz, K. Hartvigsen, S.R. Green, F. Almazan, E.A. Dennis, D. Steinberg, J.L. Witztum, and O. Quehenberger Phosphocholine as a pattern recognition ligand for CD36 J. Lipid Res. 46 2005 969 976
27. O. Boutaud, T.J. Montine, L. Chang, W.L. Klein, and J.A. Oates PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42 J. Neurochem. 96 2006 917 923
28. P.A. Boyden, S.S. Davies, P.C. Viswanathan, V. Amarnath, J.R. Balser, and L.J. Roberts 2nd Potential role of isoketals formed via the isoprostane pathway of lipid peroxidation in ischemic arrhythmias J. Cardiovasc. Pharmacol. 50 2007 480 486
29. C.J. Brame, O. Boutaud, S.S. Davies, T. Yang, J.A. Oates, D. Roden, and L.J. Roberts 2nd Modification of proteins by isoketal-containing oxidized phospholipids J. Biol. Chem. 279 2004 13447 13451
30. C.J. Brame, R.G. Salomon, J.D. Morrow, and L.J. Roberts 2nd Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts J. Biol. Chem. 274 1999 13139 13146
31. M.A. Brantley Jr., M.P. Osborn, B.J. Sanders, K.A. Rezaei, P. Lu, C. Li, G.L. Milne, J. Cai, and P. Sternberg Jr. Plasma biomarkers of oxidative stress and genetic variants in age-related macular degeneration Am. J. Ophthalmol. 153 2012 460 467 e461
32. C.M. Breitling-Utzmann, A. Unger, D.A. Friedl, and M.O. Lederer Identification and quantification of phosphatidylethanolamine-derived glucosylamines and aminoketoses from human erythrocytes - influence of glycation products on lipid peroxidation Arch. Biochem. Biophys. 391 2001 245 254
33. B.E. Brown, I. Rashid, D.M. van Reyk, and M.J. Davies Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages FEBS J. 274 2007 1530 1541
34. R. Bucala, Z. Makita, T. Koschinsky, A. Cerami, and H. Vlassara Lipid advanced glycosylation: pathway for lipid oxidation in vivo Proc. Natl. Acad. Sci. U. S. A. 90 1993 6434 6438
35. P.C. Burcham, and Y.T. Kuhan Introduction of carbonyl groups into proteins by the lipid peroxidation product, malondialdehyde Biochem. Biophys. Res. Commun. 220 1996 996 1001
36. M.S. Caplan, M. Lickerman, L. Adler, G.N. Dietsch, and A. Yu The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis Pediatr. Res. 42 1997 779 783
37. M.J. Caslake, and C.J. Packard Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke Nat. Clin. Pract. Cardiovasc. Med. 2 2005 529 535
38. V. Cecarini, Q. Ding, and J.N. Keller Oxidative inactivation of the proteasome in Alzheimer's disease Free Radic. Res. 41 2007 673 680
39. C. Charvet, W.L. Liao, G.Y. Heo, J. Laird, R.G. Salomon, I.V. Turko, and I.A. Pikuleva Isolevuglandins and mitochondrial enzymes in the retina: mass spectrometry detection of post-translational modification of sterol-metabolizing CYP27A1 J. Biol. Chem. 286 2011 20413 20422
40. C.D. Charvet, J. Laird, Y. Xu, R.G. Salomon, and I.A. Pikuleva Posttranslational modification by an isolevuglandin diminishes activity of the mitochondrial cytochrome P450 27A1 J. Lipid Res. 54 2013 1421 1429
41. C.D. Charvet, A. Saadane, M. Wang, R.G. Salomon, H. Brunengraber, I.V. Turko, and I.A. Pikuleva Pretreatment with pyridoxamine mitigates isolevuglandin-associated retinal effects in mice exposed to bright light J. Biol. Chem. 288 2013 29267 29280
42. S. Chatterjee, J.A. Berliner, G.G. Subbanagounder, A.K. Bhunia, and S. Koh Identification of a biologically active component in minimally oxidized low density lipoprotein (MM-LDL) responsible for aortic smooth muscle cell proliferation Glycoconj. J. 20 2004 331 338
43. J. Chen, J.H. Capdevila, D.C. Zeldin, and R.L. Rosenberg Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids Mol. Pharmacol. 55 1999 288 295
44. R. Chen, E. Brady, and T.M. McIntyre Human TMEM30a promotes uptake of antitumor and bioactive choline phospholipids into mammalian cells J. Immunol. 186 2011 3215 3225
45. R. Chen, X. Chen, R.G. Salomon, and T.M. McIntyre Platelet activation by low concentrations of intact oxidized LDL particles involves the PAF receptor Arterioscler. Thromb. Vasc. Biol. 29 2009 363 371
46. R. Chen, A.E. Feldstein, and T.M. McIntyre Suppression of mitochondrial function by oxidatively truncated phospholipids is reversible, aided by bid, and suppressed by Bcl-XL J. Biol. Chem. 284 2009 26297 26308
47. R. Chen, L. Yang, and T.M. McIntyre Cytotoxic phospholipid oxidation products cell death from mitochondrial damage and the intrinsic caspase cascade J. Biol. Chem. 282 2007 24842 24850
48. O.A. Cherepanova, N.A. Pidkovka, O.F. Sarmento, T. Yoshida, Q. Gan, E. Adiguzel, M.P. Bendeck, J. Berliner, N. Leitinger, and G.K. Owens Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration Circ. Res. 104 2009 609 618
49. C. Chiabrando, A. Valagussa, C. Rivalta, T. Durand, A. Guy, E. Zuccato, P. Villa, J.C. Rossi, and R. Fanelli Identification and measurement of endogenous beta-oxidation metabolites of 8-epi-prostaglandin F2alpha J. Biol. Chem. 274 1999 1313 1319
50. H.W. Chu, S. Balzar, J.Y. Westcott, J.B. Trudeau, Y. Sun, D.J. Conrad, and S.E. Wenzel Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition Clin. Exp. Allergy: J. Br. Soc. Allergy Clin. Immunol. 32 2002 1558 1565
51. D.L. Clarke, M.G. Belvisi, E. Hardaker, R. Newton, and M.A. Giembycz E-ring 8-isoprostanes are agonists at EP2- and EP4-prostanoid receptors on human airway smooth muscle cells and regulate the release of colony-stimulating factors by activating cAMP-dependent protein kinase Mol. Pharmacol. 67 2005 383 393
52. A.L. Cole, G. Subbanagounder, S. Mukhopadhyay, J.A. Berliner, and D.K. Vora Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway Arterioscler. Thromb. Vasc. Biol. 23 2003 1384 1390
53. J.L. Cracowski, P. Devillier, O. Chavanon, F.A. Sietchiping-Nzepa, F. Stanke-Labesque, and G. Bessard Isoprostaglandin E2 type-III (8-iso-prostaglandin E2) evoked contractions in the human internal mammary artery Life Sci. 68 2001 2405 2413
54. C.R. Crowe, K. Chen, D.A. Pociask, J.F. Alcorn, C. Krivich, R.I. Enelow, T.M. Ross, J.L. Witztum, and J.K. Kolls Critical role of IL-17RA in immunopathology of influenza infection J. Immunol. 183 2009 5301 5310
55. D. Cruz, A.D. Watson, C.S. Miller, D. Montoya, M.T. Ochoa, P.A. Sieling, M.A. Gutierrez, M. Navab, S.T. Reddy, J.L. Witztum, A.M. Fogelman, T.H. Rea, D. Eisenberg, J. Berliner, and R.L. Modlin Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy J. Clin. Invest. 118 2008 2917 2928
56. S. Cushing, J. Berliner, A. Valente, M. Territo, M. Navab, F. Parhami, R.G. Gerrity, C. Schwartz, and A. Fogelman Minimally modified low density lipoprotein induces monocyte chemotactic protein (MCP-1) in human endothelial and smooth muscle cells Proc. Natl. Acad. Sci. U. S. A. 87 1990 5134 5138
57. N. Dada, N.W. Kim, and R.L. Wolfert Lp-PLA2: an emerging biomarker of coronary heart disease Expert Rev. Mol. Diagn. 2 2002 17 22
58. S.S. Davies, V. Amarnath, K.S. Montine, N. Bernoud-Hubac, O. Boutaud, T.J. Montine, and L.J. Roberts 2nd Effects of reactive gamma-ketoaldehydes formed by the isoprostane pathway (isoketals) and cyclooxygenase pathway (levuglandins) on proteasome function FASEB J. 16 2002 715 717
59. S.S. Davies, C. Bodine, E. Matafonova, B.G. Pantazides, N. Bernoud-Hubac, F.E. Harrison, S.J. Olson, T.J. Montine, V. Amarnath, and I.I.L.J. Roberts Treatment with a gamma-ketoaldehyde scavenger prevents working memory deficits in hApoE4 mice J. Alzheimers Dis. 27 2011 49 59
60. 2-mediated cytotoxicity Biochemistry 45 2006 15756 15767
61. S.S. Davies, A.V. Pontsler, G.K. Marathe, K.A. Harrison, R.C. Murphy, J.C. Hinshaw, G.D. Prestwich, A.S. Hilaire, S.M. Prescott, G.A. Zimmerman, and T.M. McIntyre Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor γ ligands and agonists J. Biol. Chem. 276 2001 16015 16023
62. S.S. Davies, and L.J. Roberts 2nd F2-isoprostanes as an indicator and risk factor for coronary heart disease Free Radic. Biol. Med. 50 2011 559 566
63. S.S. Davies, M. Talati, X. Wang, R.L. Mernaugh, V. Amarnath, J. Fessel, B.O. Meyrick, J. Sheller, and L.J. Roberts 2nd Localization of isoketal adducts in vivo using a single-chain antibody Free Radic. Biol. Med. 36 2004 1163 1174
64. S.S. Davies, W. Zackert, Y. Luo, C.C. Cunningham, M. Frisard, and L.J. Roberts 2nd Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry Anal. Biochem. 348 2006 185 191
65. B. Davis, G. Koster, L.J. Douet, M. Scigelova, G. Woffendin, J.M. Ward, A. Smith, J. Humphries, K.G. Burnand, C.H. Macphee, and A.D. Postle Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein J. Biol. Chem. 283 2008 6428 6437
66. P. Delerive, C. Furman, E. Teissier, J. Fruchart, P. Duriez, and B. Staels Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner FEBS Lett. 471 2000 34 38
67. C.J. Dillard, E.E. Dumelin, and A.L. Tappel Effect of dietary vitamin E on expiration of pentane and ethane by the rat Lipids 12 1977 109 114
68. H.H. Draper, M. Hadley, L. Lissemore, N.M. Laing, and P.D. Cole Identification of N-epsilon-(2-propenal)lysine as a major urinary metabolite of malondialdehyde Lipids 23 1988 626 628
69. T. Eitsuka, K. Nakagawa, Y. Ono, N. Tatewaki, H. Nishida, T. Kurata, N. Shoji, and T. Miyazawa Amadori-glycated phosphatidylethanolamine up-regulates telomerase activity in PANC-1 human pancreatic carcinoma cells FEBS Lett. 586 2012 2542 2547
70. G. Endemann, L.W. Stanton, K.S. Madden, C.M. Bryant, R.T. White, and A.A. Protter CD36 is a receptor for oxidized low density lipoprotein J. Biol. Chem. 268 1993 11811 11816
71. R.F. Epand, V.K. Mishra, M.N. Palgunachari, G.M. Anantharamaiah, and R.M. Epand Anti-inflammatory peptides grab on to the whiskers of atherogenic oxidized lipids Biochim. Biophys. Acta 1788 2009 1967 1975
72. C. Erridge, S. Kennedy, C.M. Spickett, and D.J. Webb Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition J. Biol. Chem. 283 2008 24748 24759
73. C. Erridge, D.J. Webb, and C.M. Spickett Toll-like receptor 4 signalling is neither sufficient nor required for oxidised phospholipid mediated induction of interleukin-8 expression Atherosclerosis 193 2007 77 85
74. H. Esterbauer, A. Benedetti, J. Lang, R. Fulceri, G. Fauler, and M. Comporti Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation Biochim. Biophys. Acta 876 1986 154 166
75. H. Esterbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic. Biol. Med. 11 1991 81 128
76. L. Fang, R. Harkewicz, K. Hartvigsen, P. Wiesner, S.H. Choi, F. Almazan, J. Pattison, E. Deer, T. Sayaphupha, E.A. Dennis, J.L. Witztum, S. Tsimikas, and Y.I. Miller Oxidized cholesteryl esters and phospholipids in zebrafish larvae fed a high cholesterol diet: macrophage binding and activation J. Biol. Chem. 285 2010 32343 32351
77. A.E. Feldstein, R. Lopez, T.A. Tamimi, L. Yerian, Y.M. Chung, M. Berk, R. Zhang, T.M. McIntyre, and S.L. Hazen Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis J. Lipid Res. 51 2010 3046 3054
78. R. Felde, and G. Spiteller Plasmalogen oxidation in human serum lipoproteins Chem. Phys. Lipids 76 1995 259 267
79. J.P. Fessel, C. Hulette, S. Powell, L.J. Roberts 2nd, and J. Zhang Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease J. Neurochem. 85 2003 645 650
80. J.P. Fessel, N.A. Porter, K.P. Moore, J.R. Sheller, and L.J. Roberts 2nd Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension Proc. Natl. Acad. Sci. U. S. A. 99 2002 16713 16718
81. D. Foreman, and R.G. Solomon Evidence that the prostaglandin E2 receptor and the anhydrolevuglandin E2 receptor in the rat uterus are the same receptor Prostaglandins 43 1992 263 270
82. D. Foreman, L. Zuk, D.B. Miller, and R.G. Salomon Effects of E2 levuglandins on the contractile activity of the rat uterus Prostaglandins 34 1987 91 98
83. W.C. Fountain, J.R. Requena, A.J. Jenkins, T.J. Lyons, B. Smyth, J.W. Baynes, and S.R. Thorpe Quantification of N-(glucitol)ethanolamine and N-(carboxymethyl)serine: two products of nonenzymatic modification of aminophospholipids formed in vivo Anal. Biochem. 272 1999 48 55
84. B. Frey, R. Haupt, S. Alms, G. Holzmann, T. Konig, H. Kern, W. Kox, B. Rustow, and M. Schlame Increase in fragmented phosphatidylcholine in blood plasma by oxidative stress J. Lipid Res. 41 2000 1145 1153
85. G.O. Fruhwirth, A. Moumtzi, A. Loidl, E. Ingolic, and A. Hermetter The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells Biochim. Biophys. Acta 1761 2006 1060 1069
86. K. Fukuda, S.S. Davies, T. Nakajima, B.H. Ong, S. Kupershmidt, J. Fessel, V. Amarnath, M.E. Anderson, P.A. Boyden, P.C. Viswanathan, L.J. Roberts 2nd, and J.R. Balser Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels Circ. Res. 97 2005 1262 1269
87. Y. Fukuda, H. Kawashima, K. Saito, N. Inomata, M. Matsui, and T. Nakanishi Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models Eur. J. Pharmacol. 390 2000 203 207
88. M. Fukunaga, N. Makita, L.J. Roberts 2nd, J.D. Morrow, K. Takahashi, and K.F. Badr Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells Am. J. Physiol. 264 1993 C1619 C1624
89. M. Fukunaga, T. Yura, and K.F. Badr Stimulatory effect of 8-Epi-PGF2 alpha, an F2-isoprostane, on endothelin-1 release J. Cardiovasc. Pharmacol. 26 Suppl. 3 1995 S51 S52
90. M. Fukunaga, T. Yura, R. Grygorczyk, and K.F. Badr Evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2 Am. J. Physiol. 272 1997 F477 F483
91. A. Furuhata, T. Ishii, S. Kumazawa, T. Yamada, T. Nakayama, and K. Uchida N(epsilon)-(3-methylpyridinium)lysine, a major antigenic adduct generated in acrolein-modified protein J. Biol. Chem. 278 2003 48658 48665
92. S. Gao, R. Zhang, M.E. Greenberg, M. Sun, X. Chen, B.S. Levison, R.G. Salomon, and S.L. Hazen Phospholipid hydroxyalkenals, a subset of recently discovered endogenous CD36 ligands, spontaneously generate novel furan-containing phospholipids lacking CD36 binding activity in vivo J. Biol. Chem. 281 2006 31298 31308
93. A. Garcia-Heredia, J. Marsillach, A. Rull, I. Triguero, I. Fort, B. Mackness, M. Mackness, D.M. Shih, J. Joven, and J. Camps Paraoxonase-1 inhibits oxidized low-density lipoprotein-induced metabolic alterations and apoptosis in endothelial cells: a nondirected metabolomic study Mediators Inflamm. 2013 2013 156053
94. C. Gardi, B. Arezzini, B. Monaco, M.G. De Montis, D. Vecchio, and M. Comporti F2-isoprostane receptors on hepatic stellate cells Lab. Invest. 88 2008 124 131
95. P.S. Gargalovic, N.M. Gharavi, M.J. Clark, J. Pagnon, W.-P. Yang, A. He, A. Truong, T. Baruch-Oren, J.A. Berliner, T.G. Kirchgessner, and A.J. Lusis The unfolded protein response is an important regulator of inflammatory genes in endothelial cells Arterioscler. Thromb. Vasc. Biol. 26 2006 2490 2496
96. P.S. Gargalovic, M. Imura, B. Zhang, N.M. Gharavi, M.J. Clark, J. Pagnon, W.-P. Yang, A. He, A. Truong, S. Patel, S.F. Nelson, S. Horvath, J.A. Berliner, T.G. Kirchgessner, and A.J. Lusis Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids Proc. Natl. Acad. Sci. U. S. A. 103 2006 12741 12746
97. N.M. Gharavi, P.S. Gargalovic, I. Chang, J.A. Araujo, M.J. Clark, W.L. Szeto, A.D. Watson, A.J. Lusis, and J.A. Berliner High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory Arterioscler. Thromb. Vasc. Biol. 27 2007 1346 1353
98. K. Gillotte-Taylor, A. Boullier, J.L. Witztum, D. Steinberg, and O. Quehenberger Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein J. Lipid Res. 42 2001 1474 1482
99. R.N. Gomes, F.A. Bozza, R.T. Amancio, A.M. Japiassu, R.C. Vianna, A.P. Larangeira, J.M. Gouvea, M.S. Bastos, G.A. Zimmerman, D.M. Stafforini, S.M. Prescott, P.T. Bozza, and H.C. Castro-Faria-Neto Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis Shock 26 2006 41 49
100. M.S. Gopfert, F. Siedler, W. Siess, and A. Sellmayer Structural identification of oxidized acyl-phosphatidylcholines that induce platelet activation J. Vasc. Res. 42 2005 120 132
101. B. Govindarajan, A. Junk, M. Algeciras, R.G. Salomon, and S.K. Bhattacharya Increased isolevuglandin-modified proteins in glaucomatous astrocytes Mol. Vis. 15 2009 1079 1091
102. B. Govindarajan, J. Laird, R.G. Salomon, and S.K. Bhattacharya Isolevuglandin-modified proteins, including elevated levels of inactive calpain-1, accumulate in glaucomatous trabecular meshwork Biochemistry 47 2008 817 825
103. M.E. Greenberg, X.M. Li, B.G. Gugiu, X. Gu, J. Qin, R.G. Salomon, and S.L. Hazen The lipid whisker model of the structure of oxidized cell membranes J. Biol. Chem. 283 2008 2385 2396
104. X. Gu, and R.G. Salomon Fragmentation of a linoleate-derived gamma-hydroperoxy-alpha,beta-unsaturated epoxide to gamma-hydroxy- and gamma-oxo-alkenals involves a unique pseudo-symmetrical diepoxycarbinyl radical Free Radic. Biol. Med. 52 2012 601 606
105. M. Guichardant, N. Bernoud-Hubac, B. Chantegrel, C. Deshayes, and M. Lagarde Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids Prostaglandins Leukot. Essent. Fatty Acids 67 2002 147 149
106. M. Guichardant, P. Taibi-Tronche, L.B. Fay, and M. Lagarde Covalent modifications of aminophospholipids by 4-hydroxynonenal Free Radic. Biol. Med. 25 1998 1049 1056
107. L. Guo, Z. Chen, V. Amarnath, and S.S. Davies Identification of novel bioactive aldehyde-modified phosphatidylethanolamines formed by lipid peroxidation Free Radic. Biol. Med. 53 2012 1226 1238
108. L. Guo, Z. Chen, B.E. Cox, V. Amarnath, R.F. Epand, R.M. Epand, and S.S. Davies Phosphatidylethanolamines modified by gamma-ketoaldehyde (gammaKA) induce endoplasmic reticulum stress and endothelial activation J. Biol. Chem. 286 2011 18170 18180
109. L. Guo, S.D. Gragg, Z. Chen, Y. Zhang, V. Amarnath, and S.S. Davies Isolevuglandin-modified phosphatidylethanolamine is metabolized by NAPE-hydrolyzing phospholipase D J. Lipid Res. 54 2013 3151 3157
110. T. Hakkinen, J.S. Luoma, M.O. Hiltunen, C.H. Macphee, K.J. Milliner, L. Patel, S.Q. Rice, D.G. Tew, K. Karkola, and S. Yla-Herttuala Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions Arterioscler. Thromb. Vasc. Biol. 19 1999 2909 2917
111. L.M. Halasiddappa, H. Koefeler, A.H. Futerman, and A. Hermetter Oxidized phospholipids induce ceramide accumulation in RAW 264.7 macrophages: role of ceramide synthases PLoS ONE 8 2013 e70002
112. B. Halvorsen, A.C. Staff, T. Henriksen, T. Sawamura, and T. Ranheim 8-iso-prostaglandin F(2alpha) increases expression of LOX-1 in JAR cells Hypertension 37 2001 1184 1190
113. V.J. Hammond, A.H. Morgan, S. Lauder, C.P. Thomas, S. Brown, B.A. Freeman, C.M. Lloyd, J. Davies, A. Bush, A.L. Levonen, E. Kansanen, L. Villacorta, Y.E. Chen, N. Porter, Y.M. Garcia-Diaz, F.J. Schopfer, and V.B. O'Donnell Novel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-gamma J. Biol. Chem. 287 2012 41651 41666
114. M. Hase, M. Tanaka, M. Yokota, and Y. Yamada Reduction in the extent of atherosclerosis in apolipoprotein E-deficient mice induced by electroporation-mediated transfer of the human plasma platelet-activating factor acetylhydrolase gene into skeletal muscle Prostaglandins Other Lipid Mediat. 70 2002 107 118
115. K. Hattori, H. Adachi, A. Matsuzawa, K. Yamamoto, M. Tsujimoto, J. Aoki, M. Hattori, H. Arai, and K. Inoue cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase. II. Its homology with plasma PAF acetylhydrolase J. Biol. Chem. 271 1996 33032 33038
116. J.M. Heery, M. Kozak, D.M. Stafforini, D.A. Jones, G.A. Zimmerman, T.M. McIntyre, and S.M. Prescott Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells J. Clin. Invest. 96 1995 2322 2330
117. S. Hisaka, N. Yamada, K. Naito, and T. Osawa The immunological and chemical detection of N-(hexanoyl)phosphatidylethanolamine and N-(hexanoyl)phosphatidylserine in an oxidative model induced by carbon tetrachloride Biochem. Biophys. Res. Commun. 393 2010 631 636
118. S.W. Hoffman, S. Moore, and E.F. Ellis Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles Stroke 28 1997 844 849
119. X. Hou, L.J. Roberts 2nd, F. Gobeil Jr., D. Taber, K. Kanai, D. Abran, S. Brault, D. Checchin, F. Sennlaub, P. Lachapelle, D. Varma, and S. Chemtob Isomer-specific contractile effects of a series of synthetic F2-isoprostanes on retinal and cerebral microvasculature Free Radic. Biol. Med. 36 2004 163 172
120. J. Huber, A. Vales, G. Mitulovic, M. Blumer, R. Schmid, J.L. Witztum, B.R. Binder, and N. Leitinger Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions Arterioscler. Thromb. Vasc. Biol. 22 2002 101 107
121. K. Ikeda, M. Mutoh, N. Teraoka, H. Nakanishi, K. Wakabayashi, and R. Taguchi Increase of oxidant-related triglycerides and phosphatidylcholines in serum and small intestinal mucosa during development of intestinal polyp formation in Min mice Cancer Sci. 102 2011 79 87
122. Y. Ikura, M. Ohsawa, T. Suekane, H. Fukushima, H. Itabe, H. Jomura, S. Nishiguchi, T. Inoue, T. Naruko, S. Ehara, N. Kawada, T. Arakawa, and M. Ueda Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression Hepatology 43 2006 506 514
123. Y. Imai, K. Kuba, G.G. Neely, R. Yaghubian-Malhami, T. Perkmann, G. van Loo, M. Ermolaeva, R. Veldhuizen, Y.H. Leung, H. Wang, H. Liu, Y. Sun, M. Pasparakis, M. Kopf, C. Mech, S. Bavari, J.S. Peiris, A.S. Slutsky, S. Akira, M. Hultqvist, R. Holmdahl, J. Nicholls, C. Jiang, C.J. Binder, and J.M. Penninger Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury Cell 133 2008 235 249
124. H. Inoue, T. Tanabe, and K. Umesono Feedback control of cyclooxygenase-2 expression through PPARgamma J. Biol. Chem. 275 2000 28028 28032
125. T. Inoue, A. Sugimoto, Y. Suzuki, M. Yamamoto, M. Tsujimoto, K. Inoue, J. Aoki, and H. Arai Type II platelet-activating factor-acetylhydrolase is essential for epithelial morphogenesis in Caenorhabditis elegans Proc. Natl. Acad. Sci. U. S. A. 101 2004 13233 13238
126. U. Jahn, J.M. Galano, and T. Durand Beyond prostaglandins - chemistry and biology of cyclic oxygenated metabolites formed by free-radical pathways from polyunsaturated fatty acids Angew. Chem. Int. Ed. Engl. 47 2008 5894 5955
127. J. Jamil, A. Wright, N. Harrison, E. Kegey, A.F. Flowers, N.J. Flyod, C. Kotera, A. Guy, J.M. Galano, T. Durand, Y.F. Njie-Mbye, S.E. Ohia, and C.A. Opere Regulation of [(3)H]d-aspartate release by the 5-F(2t)-isoprostane and its 5-epimer in isolated bovine retina Neurochem. Res. 37 2012 574 582
128. L.J. Janssen, and T. Tazzeo Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature J. Pharmacol. Exp. Ther. 301 2002 1060 1066
129. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
130. W. Jira, and G. Spiteller Plasmalogens and their oxidative degradation products in low and high density lipoproteins Chem. Phys. Lipids 79 1996 95 100
131. S.R. Johnstone, J. Ross, M.J. Rizzo, A.C. Straub, P.D. Lampe, N. Leitinger, and B.E. Isakson Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferation Am. J. Pathol. 175 2009 916 924
132. M.E. Jung, J.A. Berliner, D. Angst, D. Yue, L. Koroniak, A.D. Watson, and R. Li Total synthesis of the epoxy isoprostane phospholipids PEIPC and PECPC Org. Lett. 7 2005 3933 3935
133. M.E. Jung, J.A. Berliner, L. Koroniak, B.G. Gugiu, and A.D. Watson Improved synthesis of the epoxy isoprostane phospholipid PEIPC and its reactivity with amines Org. Lett. 10 2008 4207 4209
134. A. Kadl, P.R. Sharma, W. Chen, R. Agrawal, A.K. Meher, S. Rudraiah, N. Grubbs, R. Sharma, and N. Leitinger Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2 Free Radic. Biol. Med. 51 2011 1903 1909
135. A. Karara, S. Wei, D. Spady, L. Swift, J.H. Capdevila, and J.R. Falck Arachidonic acid epoxygenase: structural characterization and quantification of epoxyeicosatrienoates in plasma Biochem. Biophys. Res. Commun. 182 1992 1320 1325
136. T. Kawai, and S. Akira Toll-like receptors and their crosstalk with other innate receptors in infection and immunity Immunity 34 2011 637 650
137. Y. Kawai, A. Ogamo, and Y. Nakagawa Formation of the aldehydic choline glycerophospholipids in human red blood cell membrane peroxidized with an azo initiator J. Biochem. 126 1999 115 120
138. K.A. Kayganich-Harrison, D.M. Rose, R.C. Murphy, J.D. Morrow, and L.J. Roberts 2nd Collision-induced dissociation of F2-isoprostane-containing phospholipids J. Lipid Res. 34 1993 1229 1235
139. R.J. Keith, P. Haberzettl, E. Vladykovskaya, B.G. Hill, K. Kaiserova, S. Srivastava, O. Barski, and A. Bhatnagar Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts Chem. Biol. Interact. 178 2009 242 249
140. J.N. Keller, K.B. Hanni, and W.R. Markesbery Impaired proteasome function in Alzheimer's disease J. Neurochem. 75 2000 436 439
141. F.T. Khasawneh, J.-S. Huang, F. Mir, S. Srinivasan, C. Tiruppathi, and G.C. Le Breton Characterization of isoprostane signaling: Evidence for a unique coordination profile of 8-iso-PGF2α with the thromboxane A2 receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets Biochem. Pharmacol. 75 2008 2301 2315
142. K. Kikugawa, H. Kosugi, and T. Asakura Effect of malondialdehyde, a product of lipid peroxidation, on the function and stability of hemoglobin Arch.
143. M.J. Kim, N.Y. Choi, J.E. Koo, S.Y. Kim, S.M. Joung, E. Jeong, and J.Y. Lee Suppression of Toll-like receptor 4 activation by endogenous oxidized phosphatidylcholine, KOdiA-PC by inhibiting LPS binding to MD2 Inflamm. Res. 62 2013 571 580
144. M.D. Knutson, G.J. Handelman, and F.E. Viteri Methods for measuring ethane and pentane in expired air from rats and humans Free Radic. Biol. Med. 28 2000 514 519
145. N. Kono, T. Inoue, Y. Yoshida, H. Sato, T. Matsusue, H. Itabe, E. Niki, J. Aoki, and H. Arai Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo J. Biol. Chem. 283 2008 1628 1636
146. T. Kriska, G.K. Marathe, J.C. Schmidt, T.M. McIntyre, and A.W. Girotti Phospholipase action of platelet-activating factor acetylhydrolase, but not paraoxonase-1, on long fatty acyl chain phospholipid hydroperoxides J. Biol. Chem. 282 2007 100 108
147. H. Kumar, T. Kawai, and S. Akira Pathogen recognition by the innate immune system Int. Rev. Immunol. 30 2011 16 34
148. P. Kunapuli, J.A. Lawson, J. Rokach, and G.A. FitzGerald Functional characterization of the ocular prostaglandin F2alpha (PGF2alpha) receptor. Activation by the isoprostane, 12-iso-PGF2alpha J. Biol. Chem. 272 1997 27147 27154
149. E. Lai, T. Teodoro, and A. Volchuk Endoplasmic reticulum stress: signaling the unfolded protein response Physiology 22 2007 193 201
150. M. Lappas, M. Permezel, S.J. Holdsworth, G. Zanoni, A. Porta, and G.E. Rice Antiinflammatory effects of the cyclopentenone isoprostane 15-A(2)-IsoP in human gestational tissues Free Radic. Biol. Med. 42 2007 1791 1796
151. C. Latchoumycandane, G.K. Marathe, R. Zhang, and T.M. McIntyre Oxidatively truncated phospholipids are required agents of tumor necrosis factor alpha (TNFalpha)-induced apoptosis J. Biol. Chem. 287 2012 17693 17705
152. W. Lebel, K. Riccardi, W.A. Grasser, K. Terry, D. Thompson, and V.M. Paralkar Prostaglandin E2 receptor subtype EP-2 is not involved in the induction of non-pregnant guinea pig uterine contractions associated with terminal pregnancy Prostaglandins Leukot. Essent. Fatty Acids 71 2004 399 404
153. M.O. Lederer, and M. Baumann Formation of a phospholipid-linked pyrrolecarbaldehyde from model reactions of d-glucose and 3-deoxyglucosone with phosphatidyl ethanolamine Bioorg. Med. Chem. 8 2000 115 121
154. E.S. Lee, J. Jiang, G.C. Sund, W.T. Simonson, J. Graham, G. Dietsch, B. Schimpf, S. Bieg, G. Peterman, and A. Lernmark Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat Diabetes 48 1999 43 49
155. H. Lee, W. Shi, P. Tontonoz, S. Wang, G. Subbanagounder, C.C. Hedrick, S. Hama, C. Borromeo, R.M. Evans, J.A. Berliner, and L. Nagy Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells Circ. Res. 87 2000 516 521
156. H.A. Lehr, J. Seemuller, C. Hubner, M.D. Menger, and K. Messmer Oxidized LDL-induced leukocyte/endothelium interaction in vivo involves the receptor for platelet-activating factor Arterioscler. Thromb. 13 1993 1013 1018
157. N. Leitinger, T.R. Tyner, L. Oslund, C. Rizza, G. Subbanagounder, H. Lee, P.T. Shih, N. Mackman, G. Tigyi, M.C. Territo, J.A. Berliner, and D.K. Vora Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils Proc. Natl. Acad. Sci. U. S. A. 96 1999 12010 12015
158. N. Leitinger, A.D. Watson, K.F. Faull, A.M. Fogelman, and J.A. Berliner Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist Adv. Exp. Med. Biol. 433 1997 379 382
159. S. Lertsiri, M. Shiraishi, and T. Miyazawa Identification of deoxy-d-fructosyl phosphatidylethanolamine as a non-enzymic glycation product of phosphatidylethanolamine and its occurrence in human blood plasma and red blood cells Biosci. Biotechnol. Biochem. 62 1998 893 901
160. V. Levi, A.M. Villamil Giraldo, P.R. Castello, J.P. Rossi, and F.L. Gonzalez Flecha Effects of phosphatidylethanolamine glycation on lipid-protein interactions and membrane protein thermal stability Biochem. J. 416 2008 145 152
161. R. Li, K.P. Mouillesseaux, D. Montoya, D. Cruz, N. Gharavi, M. Dun, L. Koroniak, and J.A. Berliner Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC Circ. Res. 98 2006 642 650
162. W. Li, J.M. Laird, L. Lu, S. Roychowdhury, L.E. Nagy, R. Zhou, J.W. Crabb, and R.G. Salomon Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts Free Radic. Biol. Med. 47 2009 1539 1552
163. J. Liu, R. Chen, G.K. Marathe, M. Febbraio, W. Zou, and T.M. McIntyre Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/PAF acetylhydrolase Circ. Res. 108 2011 469 477
164. A. Loidl, E. Sevcsik, G. Riesenhuber, H.P. Deigner, and A. Hermetter Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells J. Biol. Chem. 278 2003 32921 32928
165. M. Lopez Salon, L. Pasquini, M. Besio Moreno, J.M. Pasquini, and E. Soto Relationship between beta-amyloid degradation and the 26S proteasome in neural cells Exp. Neurol. 180 2003 131 143
166. B. Manavalan, S. Basith, and S. Choi Similar structures but different roles - an updated perspective on TLR structures Frontiers Physiol. 2 2011 41
167. G.K. Marathe, S.S. Davies, K.A. Harrison, A.R. Silva, R.C. Murphy, H. Castro-Faria-Neto, S.M. Prescott, G.A. Zimmerman, and T.M. McIntyre Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines J. Biol. Chem. 274 1999 28395 28404
168. G.K. Marathe, C. Johnson, S.D. Billings, M.D. Southall, Y. Pei, D. Spandau, R.C. Murphy, G.A. Zimmerman, T.M. McIntyre, and J.B. Travers Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage J. Biol. Chem. 280 2005 35448 35457
169. B.H. Maskrey, A. Bermudez-Fajardo, A.H. Morgan, E. Stewart-Jones, V. Dioszeghy, G.W. Taylor, P.R. Baker, B. Coles, M.J. Coffey, H. Kuhn, and V.B. O'Donnell Activated platelets and monocytes generate four hydroxyphosphatidylethanolamines via lipoxygenase J. Biol. Chem. 282 2007 20151 20163
170. A. Matsuzawa, K. Hattori, J. Aoki, H. Arai, and K. Inoue Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II J. Biol. Chem. 272 1997 32315 32320
171. D. Milatovic, and M. Aschner Measurement of isoprostanes as markers of oxidative stress in neuronal tissue Curr. Protoc. Toxicol. 2009 14 (Chapter 12, Unit 12)
172. Y.I. Miller, S. Viriyakosol, D.S. Worrall, A. Boullier, S. Butler, and J.L. Witztum Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages Arterioscler. Thromb. Vasc. Biol. 25 2005 1213 1219
173. G.L. Milne, L. Gao, A. Porta, G. Zanoni, G. Vidari, and J.D. Morrow Identification of the major urinary metabolite of the highly reactive cyclopentenone isoprostane 15-A(2t)-isoprostane in vivo J. Biol. Chem. 280 2005 25178 25184
174. G.L. Milne, E.S. Musiek, and J.D. Morrow F2-isoprostanes as markers of oxidative stress in vivo: an overview Biomarkers 10 Suppl. 1 2005 S10 S23
175. G.L. Milne, H. Yin, K.D. Hardy, S.S. Davies, and L.J. Roberts 2nd Isoprostane generation and function Chem. Rev. 111 2011 5973 5996
176. J.H. Min, C. Wilder, J. Aoki, H. Arai, K. Inoue, L. Paul, and M.H. Gelb Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme Biochemistry 40 2001 4539 4549
177. V.K. Mishra, M.N. Palgunachari, J.S. Hudson, R. Shin, T.D. Keenum, N.R. Krishna, and G.M. Anantharamaiah Structure and lipid interactions of an anti-inflammatory and anti-atherogenic 10-residue class G(*) apolipoprotein J peptide using solution NMR Biochim. Biophys. Acta 1808 2011 498 507
178. M. Miyoshi, Y. Nakano, T. Sakaguchi, H. Ogi, N. Oda, K. Suenari, K. Kiyotani, R. Ozono, T. Oshima, T. Yoshida, and K. Chayama Gene delivery of paraoxonase-1 inhibits neointimal hyperplasia after arterial balloon-injury in rabbits fed a high-fat diet Hypertens. Res. 30 2007 85 91
179. E.R. Mohler, M.T. Franklin, and L.P. Adam Intracellular signaling by 8-epi-prostaglandin F2 alpha is mediated by thromboxane A2/prostaglandin endoperoxide receptors in porcine carotid arteries Biochem. Biophys. Res. Commun. 225 1996 915 923
180. K.S. Montine, J.F. Quinn, J. Zhang, J.P. Fessel, L.J. Roberts 2nd, J.D. Morrow, and T.J. Montine Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases Chem. Phys. Lipids 128 2004 117 124
181. C.R. Morales, E.S. Terry, W.E. Zackert, T.J. Montine, and J.D. Morrow Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay Clin. Chim. Acta 314 2001 93 99
182. O.H. Morand, R.A. Zoeller, and C.R. Raetz Disappearance of plasmalogens from membranes of animal cells subjected to photosensitized oxidation J. Biol. Chem. 263 1988 11597 11606
183. E.J. Morcillo, and J. Cortijo Mucus and MUC in asthma Curr. Opin. Pulm. Med. 12 2006 1 6
184. A.H. Morgan, V. Dioszeghy, B.H. Maskrey, C.P. Thomas, S.R. Clark, S.A. Mathie, C.M. Lloyd, H. Kuhn, N. Topley, B.C. Coles, P.R. Taylor, S.A. Jones, and V.B. O'Donnell Phosphatidylethanolamine-esterified eicosanoids in the mouse: tissue localization and inflammation-dependent formation in Th-2 disease J. Biol. Chem. 284 2009 21185 21191
185. J.D. Morrow, T.A. Minton, C.R. Mukundan, M.D. Campbell, W.E. Zackert, V.C. Daniel, K.F. Badr, I.A. Blair, and L.J. Roberts 2nd Free radical-induced generation of isoprostanes in vivo: evidence for the formation of D-ring and E-ring isoprostanes J. Biol. Chem. 269 1994 4317 4326
186. J.D. Morrow, W.E. Zackert, J.P. Yang, E.H. Kurhts, D. Callewaert, R. Dworski, K. Kanai, D. Taber, K. Moore, J.A. Oates, and L.J. Roberts Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay Anal. Biochem. 269 1999 326 331
187. 2+ release, and RhoA activation J. Thorac. Cardiovasc. Surg. 135 2008 131 138
188. K.K. Murthi, L.R. Friedman, N.L. Oleinick, and R.G. Salomon Formation of DNA-protein cross-links in mammalian cells by levuglandin E2 Biochemistry 32 1993 4090 4097
189. B.R. Mwaikambo, F. Sennlaub, H. Ong, S. Chemtob, and P. Hardy Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization Invest. Ophthalmol. Vis. Sci. 47 2006 4356 4364
190. D.V. Nadkarni, and L.M. Sayre Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal Chem. Res. Toxicol. 8 1995 284 291
191. K. Nakagawa, J.H. Oak, and T. Miyazawa Angiogenic potency of Amadori-glycated phosphatidylethanolamine Ann. N. Y. Acad. Sci. 1043 2005 413 416
192. T. Nakajima, S.S. Davies, E. Matafonova, F. Potet, V. Amarnath, K.A. Tallman, R.A. Serwa, N.A. Porter, J.R. Balser, S. Kupershmidt, and L.J. Roberts 3rd Selective gamma-ketoaldehyde scavengers protect Nav1.5 from oxidant-induced inactivation J. Mol. Cell. Cardiol. 48 2010 352 359
193. T. Nakamura, D.L. Bratton, and R.C. Murphy Analysis of epoxyeicosatrienoic and monohydroxyeicosatetraenoic acids esterified to phospholipids in human red blood cells by electrospray tandem mass spectrometry J. Mass Spectrom. 32 1997 888 896
194. J. Oak, K. Nakagawa, and T. Miyazawa Synthetically prepared Aamadori-glycated phosphatidylethanolaminecan trigger lipid peroxidation via free radical reactions FEBS Lett. 481 2000 26 30
195. J.H. Oak, K. Nakagawa, and T. Miyazawa UV analysis of Amadori-glycated phosphatidylethanolamine in foods and biological samples J. Lipid Res. 43 2002 523 529
196. J.H. Oak, K. Nakagawa, S. Oikawa, and T. Miyazawa Amadori-glycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells FEBS Lett. 555 2003 419 423
197. T. Obsil, E. Amler, V. Obsilova, and Z. Pavlicek Effect of aminophospholipid glycation on order parameter and hydration of phospholipid bilayer Biophys. Chem. 80 1999 165 177
198. G. Odabaei, D. Chatterjee, A.R. Jazirehi, L. Goodglick, K. Yeung, and B. Bonavida Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis Adv. Cancer Res. 91 2004 169 200
199. S. Omarova, C.D. Charvet, R.E. Reem, N. Mast, W. Zheng, S. Huang, N.S. Peachey, and I.A. Pikuleva Abnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis J. Clin. Invest. 122 2012 3012 3023
200. C.A. Opere, W.D. Zheng, J. Huang, A. Adewale, M. Kruglet, and S.E. Ohia Dual effect of isoprostanes on the release of [3H]d-aspartate from isolated bovine retinae: role of arachidonic acid metabolites Neurochem. Res. 30 2005 129 137
201. G. Ostermann, G.M. Kostner, A. Gries, E. Malle, and U. Till The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum Haemostasis 19 1989 160 168
202. C.J. Packard, D.S. O'Reilly, M.J. Caslake, A.D. McMahon, I. Ford, J. Cooney, C.H. Macphee, K.E. Suckling, M. Krishna, F.E. Wilkinson, A. Rumley, and G.D. Lowe Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group N. Engl. J. Med. 343 2000 1148 1155
203. R. Pamplona, M.J. Bellmunt, M. Portero, D. Riba, and J. Prat Chromatographic evidence for Amadori product formation in rat liver aminophospholipids Life Sci. 57 1995 873 879
204. B.S. Park, D.H. Song, H.M. Kim, B.S. Choi, H. Lee, and J.O. Lee The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex Nature 458 2009 1191 1195
205. K.D. Patel, G.A. Zimmerman, S.M. Prescott, and T.M. McIntyre Novel leukocyte agonists are released by endothelial cells exposed to peroxide J. Biol. Chem. 267 1992 15168 15175
206. S. Pegorier, D. Stengel, H. Durand, M. Croset, and E. Ninio Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophages. Implications in atherosclerosis Atherosclerosis 188 2006 433 443
207. N.A. Pidkovka, O.A. Cherepanova, T. Yoshida, M.R. Alexander, R.A. Deaton, J.A. Thomas, N. Leitinger, and G.K. Owens Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro Circ. Res. 101 2007 792 801
208. E.A. Podrez, T.V. Byzova, M. Febbraio, R.G. Salomon, Y. Ma, M. Valiyaveettil, E. Poliakov, M. Sun, P.J. Finton, B.R. Curtis, J. Chen, R. Zhang, R.L. Silverstein, and S.L. Hazen Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype Nat. Med. 13 2007 1086 1095
209. E.A. Podrez, E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P.J. Finton, L. Shan, M. Febbraio, D.P. Hajjar, R.L. Silverstein, H.F. Hoff, R.G. Salomon, and S.L. Hazen A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions J. Biol. Chem. 277 2002 38517 38523
210. E.A. Podrez, E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P.J. Finton, L. Shan, B. Gugiu, P.L. Fox, H.F. Hoff, R.G. Salomon, and S.L. Hazen Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36 J. Biol. Chem. 277 2002 38503 38516
211. E. Poliakov, S.G. Meer, S.C. Roy, C. Mesaros, and R.G. Salomon Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro Chem. Res. Toxicol. 17 2004 613 622
212. A. Pollreisz, T. Afonyushkin, O.V. Oskolkova, F. Gruber, V.N. Bochkov, and U. Schmidt-Erfurth Retinal pigment epithelium cells produce VEGF in response to oxidized phospholipids through mechanisms involving ATF4 and protein kinase CK2 Exp. Eye Res. 116 2013 177 184
213. A.V. Pontsler, A. St Hilaire, G.K. Marathe, G.A. Zimmerman, and T.M. McIntyre Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein J. Biol. Chem. 277 2002 13029 13036
214. N.A. Porter, and L.S. Lehman Xanthine-oxidase initiated oxidation of model membranes - effect of position of abstractable hydrogen-atoms in the bilayer on the distribution of products J. Am. Chem. Soc. 104 1982 4731 4732
215. J.M. Proudfoot, A.E. Barden, W.M. Loke, K.D. Croft, I.B. Puddey, and T.A. Mori HDL is the major lipoprotein carrier of plasma F2-isoprostanes J. Lipid Res. 50 2009 716 722
216. J. Qin, F.D. Testai, S. Dawson, J. Kilkus, and G. Dawson Oxidized phosphatidylcholine formation and action in oligodendrocytes J. Neurochem. 110 2009 1388 1399
217. R. Quarck, B. De Geest, D. Stengel, A. Mertens, M. Lox, G. Theilmeier, C. Michiels, M. Raes, H. Bult, D. Collen, P. Van Veldhoven, E. Ninio, and P. Holvoet Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice Circulation 103 2001 2495 2500
218. A. Ravandi, A. Kuksis, L. Marai, and J.J. Myher Preparation and characterization of glucosylated aminoglycerophospholipids Lipids 30 1995 885 891
219. A. Ravandi, A. Kuksis, and N.A. Shaikh Glycated phosphatidylethanolamine promotes macrophage uptake of low density lipoprotein and accumulation of cholesteryl esters and triacylglycerols J. Biol. Chem. 274 1999 16494 16500
220. A. Ravandi, A. Kuksis, and N.A. Shaikh Glucosylated glycerophosphoethanolamines are the major LDL glycation products and increase LDL susceptibility to oxidation: evidence of their presence in atherosclerotic lesions Arterioscler. Thromb. Vasc. Biol. 20 2000 467 477
221. J.R. Requena, M.U. Ahmed, C.W. Fountain, T.P. Degenhardt, S. Reddy, C. Perez, T.J. Lyons, A.J. Jenkins, J.W. Baynes, and S.R. Thorpe Carboxymethylethanolamine, a biomarker of phospholipid modification during the maillard reaction in vivo J. Biol. Chem. 272 1997 17473 17479
222. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
223. L.J. Roberts II, J.P. Fessel, and S.S. Davies The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation Brain Pathol. 15 2005 143 148
224. S. Roychowdhury, M.R. McMullen, M.T. Pritchard, W. Li, R.G. Salomon, and L.E. Nagy Formation of gamma-ketoaldehyde-protein adducts during ethanol-induced liver injury in mice Free Radic. Biol. Med. 47 2009 1526 1538
225. R.G. Salomon Structural identification and cardiovascular activities of oxidized phospholipids Circ. Res. 111 2012 930 946
226. R.G. Salomon, E. Batyreva, K. Kaur, D.L. Sprecher, M.J. Schreiber, J.W. Crabb, M.S. Penn, A.M. DiCorletoe, S.L. Hazen, and E.A. Podrez Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway Biochim. Biophys. Acta 1485 2000 225 235
227. J.W. Schmidley, J. Dadson, R.S. Iyer, and R.G. Salomon Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2 Prostaglandins Leukot. Essent. Fatty Acids 47 1992 105 110
228. C. Schneider, W.E. Boeglin, H. Yin, N.A. Porter, and A.R. Brash Intermolecular peroxyl radical reactions during autoxidation of hydroxy and hydroperoxy arachidonic acids generate a novel series of epoxidized products Chem. Res. Toxicol. 21 2008 895 903
229. T.A. Seimon, M.J. Nadolski, X. Liao, J. Magallon, M. Nguyen, N.T. Feric, M.L. Koschinsky, R. Harkewicz, J.L. Witztum, S. Tsimikas, D. Golenbock, K.J. Moore, and I. Tabas Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress Cell Metab. 12 2010 467 482
230. Y. Shi, P. Zhang, L. Zhang, H. Osman, E.R. Mohler 3rd, C. Macphee, A. Zalewski, A. Postle, and R.L. Wilensky Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses Atherosclerosis 191 2007 54 62
231. D.M. Shih, Y.R. Xia, X.P. Wang, E. Miller, L.W. Castellani, G. Subbanagounder, H. Cheroutre, K.F. Faull, J.A. Berliner, J.L. Witztum, and A.J. Lusis Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis J. Biol. Chem. 275 2000 17527 17535
232. Y. Shimozu, K. Hirano, T. Shibata, N. Shibata, and K. Uchida 4-Hydroperoxy-2-nonenal is not just an intermediate but a reactive molecule that covalently modifies proteins to generate unique intramolecular oxidation products J. Biol. Chem. 286 2011 29313 29324
233. S.H. Shin, H.Y. Song, M.Y. Kim, E.K. Do, J.S. Lee, and J.H. Kim Oxidized phosphatidylcholine induces migration of bone marrow-derived mesenchymal stem cells through Kruppel-like factor 4-dependent mechanism Mol. Cell. Biochem. 352 2011 109 115
234. M.H. Shishehbor, R. Zhang, H. Medina, M.L. Brennan, D.M. Brennan, S.G. Ellis, E.J. Topol, and S.L. Hazen Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease Free Radic. Biol. Med. 41 2006 1678 1683
235. C. Simoes, A.C. Silva, P. Domingues, P. Laranjeira, A. Paiva, and M.R. Domingues Modified phosphatidylethanolamines induce different levels of cytokine expression in monocytes and dendritic cells Chem. Phys. Lipids 175/176 2013 57 64
236. P.L. Smiley, K.E. Stremler, S.M. Prescott, G.A. Zimmerman, and T.M. McIntyre Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor J. Biol. Chem. 266 1991 11104 11110
237. W.-L. Song, J.A. Lawson, D. Reilly, J. Rokach, C.-T. Chang, B. Giasson, and G.A. FitzGerald Neurofurans novel indices of oxidant stress derived from docosahexaenoic acid J. Biol. Chem. 283 2008 6 16
238. A.A. Spector, X. Fang, G.D. Snyder, and N.L. Weintraub Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function Prog. Lipid Res. 43 2004 55 90
239. A.A. Spector, and A.W. Norris Action of epoxyeicosatrienoic acids on cellular function Am. J. Physiol. Cell Physiol. 292 2007 C996 C1012
240. C.M. Spickett, and G. Dever Studies of phospholipid oxidation by electrospray mass spectrometry: from analysis in cells to biological effects Biofactors 24 2005 17 31
241. S.L. Spinelli, K.L. Lannan, A.E. Casey, A. Croasdell, T.M. Curran, K.F. Henrichs, S.J. Pollock, G.A. Milne, M.A. Refaai, C.W. Francis, R.P. Phipps, and N. Blumberg Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro Transfusion (Paris) 2013 10.1111/trf.12485 [epub ahead of print]
242. M. Spite, S.P. Baba, Y. Ahmed, O.A. Barski, K. Nijhawan, J.M. Petrash, A. Bhatnagar, and S. Srivastava Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes Biochem. J. 405 2007 95 105
243. S. Srivastava, M. Spite, J.O. Trent, M.B. West, Y. Ahmed, and A. Bhatnagar Aldose reductase-catalyzed reduction of aldehyde phospholipids J. Biol. Chem. 279 2004 53395 53406
244. S. Srivastava, E. Vladykovskaya, O.A. Barski, M. Spite, K. Kaiserova, J.M. Petrash, S.S. Chung, G. Hunt, B. Dawn, and A. Bhatnagar Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice Circ. Res. 105 2009 793 802
245. S. Stadelmann-Ingrand, S. Favreliere, B. Fauconneau, G. Mauco, and C. Tallineau Plasmalogen degradation by oxidative stress: production and disappearance of specific fatty aldehydes and fatty alpha-hydroxyaldehydes Free Radic. Biol. Med. 31 2001 1263 1271
246. S. Stadelmann-Ingrand, R. Pontcharraud, and B. Fauconneau Evidence for the reactivity of fatty aldehydes released from oxidized plasmalogens with phosphatidylethanolamine to form Schiff base adducts in rat brain homogenates Chem. Phys. Lipids 131 2004 93 105
247. D.M. Stafforini Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2) Cardiovasc. Drugs Ther. 23 2009 73 83
248. D.M. Stafforini, M.E. Carter, G.A. Zimmerman, T.M. McIntyre, and S.M. Prescott Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma Proc. Natl. Acad. Sci. U. S. A. 86 1989 2393 2397
249. D.M. Stafforini, M.R. Elstad, T.M. McIntyre, G.A. Zimmerman, and S.M. Prescott Human macrophages secret platelet-activating factor acetylhydrolase J. Biol. Chem. 265 1990 9682 9687
250. D.M. Stafforini, J.R. Sheller, T.S. Blackwell, A. Sapirstein, F.E. Yull, T.M. McIntyre, J.V. Bonventre, S.M. Prescott, and L.J. Roberts II Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases J. Biol. Chem. 281 2006 4616 4623
251. I.G. Stavrovskaya, S.V. Baranov, X. Guo, S.S. Davies, L.J. Roberts 2nd, and B.S. Kristal Reactive gamma-ketoaldehydes formed via the isoprostane pathway disrupt mitochondrial respiration and calcium homeostasis Free Radic. Biol. Med. 49 2010 567 579
252. U. Stemmer, Z.A. Dunai, D. Koller, G. Purstinger, E. Zenzmaier, H.P. Deigner, E. Aflaki, D. Kratky, and A. Hermetter Toxicity of oxidized phospholipids in cultured macrophages Lipids Health Dis. 11 2012 110
253. K.E. Stremler, D.M. Stafforini, S.M. Prescott, G.A. Zimmerman, and T.M. McIntyre An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma J. Biol. Chem. 264 1989 5331 5334
254. G. Subbanagounder, Y. Deng, C. Borromeo, A.N. Dooley, J.A. Berliner, and R.G. Salomon Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells Vascul. Pharmacol. 38 2002 201 209
255. G. Subbanagounder, N. Leitinger, P.T. Shih, K.F. Faull, and J.A. Berliner Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: in vitro and In vivo inhibition by WEB 2086 Circ. Res. 85 1999 311 318
256. G. Subbanagounder, J.W. Wong, H. Lee, K.F. Faull, E. Miller, J.L. Witztum, and J.A. Berliner Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta J. Biol. Chem. 277 2002 7271 7281
257. C.B. Sullivan, E. Matafonova, L.J. Roberts, I.I. Amarnath, and V.S.S. Davies Isoketals form cytotoxic phosphatidylethanolamine adducts in cells J. Lipid Res. 51 2010 999 1009
258. M. Sun, S.C. Finnemann, M. Febbraio, L. Shan, S.P. Annangudi, E.A. Podrez, G. Hoppe, R. Darrow, D.T. Organisciak, R.G. Salomon, R.L. Silverstein, and S.L. Hazen Light-induced oxidation of photoreceptor outer segment phospholipids generates ligands for CD36-mediated phagocytosis by retinal pigment epithelium: a potential mechanism for modulating outer segment phagocytosis under oxidant stress conditions J. Biol. Chem. 281 2006 4222 4230
259. M. Suzuki, M. Kamei, H. Itabe, K. Yoneda, H. Bando, N. Kume, and Y. Tano Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration Mol. Vis. 13 2007 772 778
260. M. Talati, B. Meyrick, R.S. Peebles Jr., S.S. Davies, R. Dworski, R. Mernaugh, D. Mitchell, M. Boothby, L.J. Roberts 2nd, and J.R. Sheller Oxidant stress modulates murine allergic airway responses Free Radic. Biol. Med. 40 2006 1210 1219
261. T. Tanaka, M. Iimori, H. Tsukatani, and A. Tokumura Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group Biochim. Biophys. Acta 1210 1994 202 208
262. 2+/ascorbate/EDTA-induced lipid peroxidation Biochim. Biophys. Acta 1166 1993 264 274
263. T. Tanaka, A. Tokumura, and H. Tsukatani Platelet-activating factor (PAF)-like phospholipids formed during peroxidation of phosphatidylcholines from different foodstuffs Biosci. Biotechnol. Biochem. 59 1995 1389 1393
264. C.P. Thomas, L.T. Morgan, B.H. Maskrey, R.C. Murphy, H. Kuhn, S.L. Hazen, A.H. Goodall, H.A. Hamali, P.W. Collins, and V.B. O'Donnell Phospholipid-esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generation J. Biol. Chem. 285 2010 6891 6903
265. D.J. Thornton, K. Rousseau, and M.A. McGuckin Structure and function of the polymeric mucins in airways mucus Annu. Rev. Physiol. 70 2008 459 486
266. L.W. Tjoelker, C. Wilder, C. Eberhardt, D.M. Stafforini, G. Dietsch, B. Schimpf, S. Hooper, H. Le Trong, L.S. Cousens, G.A. Zimmerman, Y. Yamada, T.M. McIntyre, S.M. Prescott, and P.W. Gray Anti-inflammatory properties of a platelet-activating factor acetylhydrolase Nature 374 1995 549 553
267. S. Tsimikas, E.S. Brilakis, E.R. Miller, J.P. McConnell, R.J. Lennon, K.S. Kornman, J.L. Witztum, and P.B. Berger Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease N. Engl. J. Med. 353 2005 46 57
268. S. Tsimikas, H.K. Lau, K.R. Han, B. Shortal, E.R. Miller, A. Segev, L.K. Curtiss, J.L. Witztum, and B.H. Strauss Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein Circulation 109 2004 3164 3170
269. K. Tsuji, Y. Kawai, Y. Kato, and T. Osawa Formation of N-(hexanoyl)ethanolamine, a novel phosphatidylethanolamine adduct, during the oxidation of erythrocyte membrane and low-density lipoprotein Biochem. Biophys. Res. Commun. 306 2003 706 711
270. J. Turner, and C.E. Jones Regulation of mucin expression in respiratory diseases Biochem. Soc. Trans. 37 2009 877 881
271. V.A. Tyurin, K. Balasubramanian, D. Winnica, Y.Y. Tyurina, A.S. Vikulina, R.R. He, A.A. Kapralov, C.H. Macphee, and V.E. Kagan Oxidatively modified phosphatidylserines on the surface of apoptotic cells are essential phagocytic 'eat-me' signals: cleavage and inhibition of phagocytosis by Lp-PLA Cell Death Differ. 2014 10.1038/cdd.2014.1 [Epub 2014 Jan 24]
272. K. Uchida, M. Kanematsu, Y. Morimitsu, T. Osawa, N. Noguchi, and E. Niki Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins J. Biol. Chem. 273 1998 16058 16066
273. K. Uchida, K. Sakai, K. Itakura, T. Osawa, and S. Toyokuni Protein modification by lipid peroxidation products: formation of malondialdehyde- derived N(epsilon)-(2-propenol)lysine in proteins Arch. Biochem. Biophys. 346 1997 45 52
274. S. Uderhardt, M. Herrmann, O.V. Oskolkova, S. Aschermann, W. Bicker, N. Ipseiz, K. Sarter, B. Frey, T. Rothe, R. Voll, F. Nimmerjahn, V.N. Bochkov, G. Schett, and G. Kronke 12/15-Lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance Immunity 36 2012 834 846
275. B.J. Van Lenten, A.C. Wagner, C.L. Jung, P. Ruchala, A.J. Waring, R.I. Lehrer, A.D. Watson, S. Hama, M. Navab, G.M. Anantharamaiah, and A.M. Fogelman Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I J. Lipid Res. 49 2008 2302 2311
276. B.J. Van Lenten, A.C. Wagner, M. Navab, G.M. Anantharamaiah, E.K. Hui, D.P. Nayak, and A.M. Fogelman D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes Circulation 110 2004 3252 3258
277. M. Vento, M. Moro, R. Escrig, L. Arruza, G. Villar, I. Izquierdo, L.J. Roberts 2nd, A. Arduini, J.J. Escobar, J. Sastre, and M.A. Asensi Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease Pediatrics 124 2009 e439 e449
278. E. Vladykovskaya, E. Ozhegov, J.D. Hoetker, Z. Xie, Y. Ahmed, J. Suttles, S. Srivastava, A. Bhatnagar, and O.A. Barski Reductive metabolism increases the proinflammatory activity of aldehyde phospholipids J. Lipid Res. 52 2011 2209 2225
279. E. von Schlieffen, O.V. Oskolkova, G. Schabbauer, F. Gruber, S. Bluml, M. Genest, A. Kadl, C. Marsik, S. Knapp, J. Chow, N. Leitinger, B.R. Binder, and V.N. Bochkov Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids Arterioscler. Thromb. Vasc. Biol. 29 2009 356 362
280. R.S. Wagner, C. Weare, N. Jin, E.R. Mohler, and R.A. Rhoades Characterization of signal transduction events stimulated by 8-epi-prostaglandin(PG)F2 alpha in rat aortic rings Prostaglandins 54 1997 581 599
281. W. Wahli, and L. Michalik PPARs at the crossroads of lipid signaling and inflammation Trends Endocrinol. Metab. 23 2012 351 363
282. K.A. Walton, B.G. Gugiu, M. Thomas, R.J. Basseri, D.R. Eliav, R.G. Salomon, and J.A. Berliner A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products J. Lipid Res. 47 2006 1967 1974
283. K.A. Walton, X. Hsieh, N. Gharavi, S. Wang, G. Wang, M. Yeh, A.L. Cole, and J.A. Berliner Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl- sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein J. Biol. Chem. 278 2003 29661 29666
284. L.B. Ware, J.P. Fessel, A.K. May, and L.J. Roberts 2nd Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis Shock 36 2011 12 17
285. A. Watson, M. Leitinger, M. Navab, K. Faull, S. Horkko, J. Witztum, W. Palinski, D.C. Schwenke, R. Salomon, W. Sha, G. Subbanagounder, A. Fogelman, and J. Berliner Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo J. Biol. Chem. 272 1997 13597 13607
286. A.D. Watson, M. Navab, S.Y. Hama, A. Sevanian, S.M. Prescott, D.M. Stafforini, T.M. McIntyre, B.N. Du, A.M. Fogelman, and J.A. Berliner Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein J. Clin. Invest. 95 1995 774 782
287. A.D. Watson, G. Subbanagounder, D.S. Welsbie, K.F. Faull, M. Navab, M.E. Jung, A.M. Fogelman, and J.A. Berliner Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein J. Biol. Chem. 274 1999 24787 24798
288. S.J. Wilson, K. McGinley, A.J. Huang, and E.M. Smyth Heterodimerization of the α and β isoforms of the human thromboxane receptor enhances isoprostane signaling Biochem. Biophys. Res. Commun. 352 2007 397 403
289. X. Wu, G.A. Zimmerman, S.M. Prescott, and D.M. Stafforini The p38 MAPK pathway mediates transcriptional activation of the plasma platelet-activating factor acetylhydrolase gene in macrophages stimulated with lipopolysaccharide J. Biol. Chem. 279 2004 36158 36165
290. Y. Yao, K.A. Harrison, M. Al-Hassani, R.C. Murphy, S. Rezania, R.L. Konger, and J.B. Travers Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity J. Biol. Chem. 287 2012 9311 9321
291. H. Yin, B.E. Cox, W. Liu, N.A. Porter, J.D. Morrow, and G.L. Milne Identification of intact oxidation products of glycerophospholipids in vitro and in vivo using negative ion electrospray iontrap mass spectrometry J. Mass Spectrom. 44 2009 672 680
292. T. Yoshida, Q. Gan, and G.K. Owens Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids Am. J. Physiol. Cell Physiol. 295 2008 C1175 C1182
293. I. Zagol-Ikapitte, V. Amarnath, M. Bala, L.J. Roberts 2nd, J.A. Oates, and O. Boutaud Characterization of scavengers of gamma-ketoaldehydes that do not inhibit prostaglandin biosynthesis Chem. Res. Toxicol. 23 2010 240 250
294. I. Zagol-Ikapitte, T.S. Masterson, V. Amarnath, T.J. Montine, K.I. Andreasson, O. Boutaud, and J.A. Oates Prostaglandin H(2)-derived adducts of proteins correlate with Alzheimer's disease severity J. Neurochem. 94 2005 1140 1145
295. I. Zagol-Ikapitte, E. Matafonova, V. Amarnath, C.L. Bodine, O. Boutaud, R.G. Tirona, J.A. Oates, I.I. Roberts, and L.J.S. Davies Determination of the pharmacokinetics and oral bioavailability of salicylamine, a potent gamma-ketoaldehyde scavenger, by LC/MS/MS Pharmaceutics 2 2010 18 29
296. K.A. Zemski Berry, and R.C. Murphy Characterization of acrolein-glycerophosphoethanolamine lipid adducts using electrospray mass spectrometry Chem. Res. Toxicol. 20 2007 1342 1351
297. Q. Zhang, M.D. Southall, S.M. Mezsick, C. Johnson, R.C. Murphy, R.L. Konger, and J.B. Travers Epidermal peroxisome proliferator-activated receptor gamma as a target for ultraviolet B radiation J. Biol. Chem. 280 2005 73 79
298. R. Zhang, Z. Shen, W.M. Nauseef, and S.L. Hazen Defects in leukocyte-mediated initiation of lipid peroxidation in plasma as studied in myeloperoxidase-deficient subjects: systematic identification of multiple endogenous diffusible substrates for myeloperoxidase in plasma Blood 99 2002 1802 1810
299. J. Zhao, B. Maskrey, S. Balzar, K. Chibana, A. Mustovich, H. Hu, J.B. Trudeau, V. O'Donnell, and S.E. Wenzel Interleukin-13-induced MUC5AC is regulated by 15-lipoxygenase 1 pathway in human bronchial epithelial cells Am. J. Respir. Crit. Care Med. 179 2009 782 790
300. J. Zhao, V.B. O'Donnell, S. Balzar, C.M. St Croix, J.B. Trudeau, and S.E. Wenzel 15-Lipoxygenase 1 interacts with phosphatidylethanolamine-binding protein to regulate MAPK signaling in human airway epithelial cells Proc. Natl. Acad. Sci. U. S. A. 108 2011 14246 14251
301. G.H. Zheng, S.Q. Xiong, L.J. Mei, H.Y. Chen, T. Wang, and J.F. Chu Elevated plasma platelet activating factor, platelet activating factor acetylhydrolase levels and risk of coronary heart disease or blood stasis syndrome of coronary heart disease in Chinese: a case-control study Inflammation 35 2012 1419 1428
302. S. Zieseniss, S. Zahler, I. Muller, A. Hermetter, and B. Engelmann Modified phosphatidylethanolamine as the active component of oxidized low density lipoprotein promoting platelet prothrombinase activity J. Biol. Chem. 276 2001 19828 19835